Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
This study has been completed.
Study NCT00651846   Information provided by Bayer
First Received: April 1, 2008   Last Updated: July 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Yasmin (DRSP 3mg/EE 0.03 mg)
Microgynon (LNG 0.15 mg/EE 0.03 mg)
Additional drug interventions recognized in this trial
Ethinyl Estradiol-Norgestrel Combination
Hemostatics
More general drug interventions related to this trial
Coagulants
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Combined
Contraceptives, Oral, Synthetic
Contraceptives, Postcoital
Contraceptives, Postcoital, Synthetic
Hematologic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services